ArticleNature communications2025
Fractionated degradation and valorization of polypropylene waste into sulfonate surfactants.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Tandem upcycling presents a promising approach to converting plastic waste into valuable chemicals. Controlling the chain length distribution (CLD) of hydrocarbons in plastic degradation is crucial for the downstream synthesis of high-quality and high-value functional chemicals. However, controlling the CLD remains a significant challenge due to the high randomness and poor regulation of polymer chain scission. Herein, we introduce a fractionated degradation approach to tune the CLD of hydrocarbons derived from polypropylene (PP) degradation, thereby facilitating effective downstream valorization. By designing a fractionated degradation reactor that manipulates latent heat, we achieve size-selective degradation of PP into C
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.